Recombinant human IgG1 based Fc multimers, with limited FcR binding capacity, can effectively inhibit complement-mediated diseaseHaoping Sun, Xiaoyu Zhang, Emmanuel Y. Mérigeon et al.|Journal of Autoimmunity|2017Cited by 18